Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: Randomised controlled trial

BMJ (Online)

Volumn 338, Issue 7707, 2009, Pages 1363-1365

  Hoff, Geir ^a,b,e   Grotmol, Tom ^a   Skovlund, Eva ^c   Bretthauer, Michael ^a,d  

^a Cancer Registry of Norway   (Norway)

^b TELEMARK HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGMOIDOSCOPY;

COLORECTAL NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PROGNOSIS; SIGMOIDOSCOPY;

EID: 67650076135     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b1846     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
3. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006;355:1863-72.
4. Rozen P, Winawer SJ. Report of theOMED colorectal cancer screening committee meeting, New Orleans, 2004 - in collaboration with the IDCA. Eur J Cancer Prev 2004;13:461-4.
5. Winawer SJ, Zauber AG, Ho MN, O'Brian MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
6. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined faecal occult blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
7. Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-8.
8. Loeve F, Boer R, Zauber AG, van Ballegooijen M, van Ootmarssen GJ, Winawer SJ, et al. National polyp study data: evidence for regression of adenomas. Int J Cancer 2004;111:633-9.
9. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Scand J Gastroenterol 1999;34:414-20.
10. Wilson JMG, Jungner G. Principles of practice of screening for disease. Geneva: World Health Organization, 1968.
11. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. www.screening.nhs. uk/criteria.
12. Bretthauer M, Gondal G, Larsen IK, Carlsen E, Eide TJ, Grotmol T, et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia. Scand J Gastroenterol 2002;37:568-73.
13. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian colorectal cancer prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003;38:635-42.
14. Hoff G, Sauar J, Hofstad B, Vatn MH. The national guidelines for surveillance after polypectomy: 10-year intervals. Scand J Gastroenterol 1996;31:834-6.
15. Cancer in Norway 2005. Oslo: Cancer Registry of Norway, 2006.
16. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomized trial. Lancet 2002;359:1291-300.
17. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 2002;94:1763-72.
18. Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C, et al. The colon cancer prevention program (CoCaP): rationale, implementation, and preliminary results. HMO Pract 1997;11:5-12.
19. Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial. Eur J Cancer Prev 2006;15:10-9.
20. Cuzick J, Cafferty FH, Edwards R, Møller H, Duffy SW. Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen 2007;14:178-85.
21. Seeff LC, Richards TB, Shapiro JA, Nadel MR,Manninen DL, Given LS, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 2004;127:1670-7.
22. Atkin WS, Edwards R, Wardle J, Northover JMA, Sutton S, Hart AR, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-44.
23. Rasmussen M, Kronborg O, Fenger C, Jørgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to Hemoccult-II in screening for colorectal cancer: a randomized study. Scand J Gastroenterol 1999;34:73-8.
24. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006;295:2366-73.